Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Inducible and endothelial nitric oxide synthase expression in human atherogenesis: an immunohistochemical and ultrastructural study
Cardiovascular Pathology, 11/06/09
Perrotta I et al. – The data confirm and extend previous findings of a direct relationship between dysregulation of nitric oxide pathway and atherosclerosis, suggesting another possible mechanism by which nitric oxide synthase system abnormalities may promote vascular dysfunction during human atherogenesis. Changes in nitric oxide production might be the primary step in the development of atheroma.
Related Articles
Heat-shock protein 90: A novel autoantigen in human carotid atherosclerosis
Atherosclerosis, 11/12/09
Relevance Score: 91%
Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification
Experimental Gerontology, 11/12/09
Relevance Score: 89%
Prevention of atherosclerosis with low-density lipoprotein cholesterol lowering—lipoprotein changes and interactions: the SANDS study
Journal of Clinical Lipidology, 10/14/09
Relevance Score: 89%
Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis
Atherosclerosis, 10/09/09
Relevance Score: 89%
Liver X Receptors as potential therapeutic targets in atherosclerosis
Clinical and Investigative Medicine, 10/06/09
Relevance Score: 89%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes
Journal of Hypertension, 11/25/09
The High Prevalence of Subclinical Atherosclerosis in Patients With Ankylosing Spondylitis Without Clinically Evident Cardiovascular Disease
Medicine, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


